While many programs aimed at prescription drug abuse focus
on how to stop diversion of medications, an often overlooked but
critical issue is preventing and treating opioid overdoses, according to
a Brown University researcher.
Traci Green MSc, PhD,
Assistant Professor of Emergency Medicine and Epidemiology, studied
prescription opioid overdoses in three communities in Connecticut and
Rhode Island that were experiencing a rash of deaths from opioid
overdoses in 2009.
“Our goal was to understand not just why it was happening, but what
we can do now to prevent it,” said Dr. Green, who spoke about her
research at the recent annual meeting of the Association for Medical
Education and Research in Substance Abuse.
Dr. Green and her colleagues conducted a rapid assessment and
response project, convening a community advisory board of substance
abuse treatment professionals, people in the recovery community, active
opioid users, EMS providers, and state and local officials to guide
their research. They looked at data on prescription opioid overdoses,
collected interviews with 195 people, and discussed how to respond to
the growing crisis.
Dr. Traci Green
“We found that awareness around the topic of overdose and drug
poisoning was lacking,” Dr. Green said. “People didn’t know it was a
problem. They didn’t know what an overdose looks like. It made us
realize that in these communities, there is a great deal of stigma
around prescription opioid overdoses.”
The community advisory board came up with a number of suggestions,
including working with local clinicians specializing in treating
substance abuse and chronic pain, to develop safer prescribing tools
that would be locally relevant. They devised resources for clinicians
with concerns about patient addiction or drug diversion. They created
and distributed posters and other educational materials in English and
Spanish to inform the public about opioid overdoses in the small towns
and suburban New England communities experiencing the overdose
outbreaks.
The group also made recommendations on how clinicians can talk with
their patients about oversedation and symptoms of overdose. “People
taking opioids need to talk with their loved ones or people they live
with about these issues. They also need to create a household-based
intervention for securing pills, especially if they live with young
people, because they have medication for pain control in their home that
has the potential to be a fatal poison.”
While both Connecticut and Rhode Island have prescription monitoring
programs (PMPs), they, like most such programs, are designed to thwart
“doctor shopping,” and generally do not offer resources on overdosing,
according to Dr. Green. Her group worked with the agencies that run PMPs
in those two states to provide online tools for clinicians, and to
develop materials aimed at preventing and treating overdoses.
Dr. Green found the communities she worked with were interested in programs to use
naloxone
(Narcan), a drug that safely reverses the potentially fatal side
effects of an overdose of oxycodone, heroin and other opioids. It has
been routinely used by emergency rooms and ambulance crews for decades.
In the past few years, naloxone has been distributed free to opioid
users and their loved ones, in a growing number of sites around the
country.
A recent report by the Centers for Disease Control and Prevention
(CDC) found that widely distributing naloxone, and training people in
how to use it, could save many lives. It has successfully reversed more
than 10,000 drug overdoses since 1996, according to the
CDC report.
Through the study, three substance abuse treatment centers and one
recovery center in the study communities hosted pilot programs of
prescribed take-home naloxone. They continue to offer the medication to
clients, as part of the Connecticut Department of Mental Health and
Addiction Services’
new naloxone initiative.
As a result of increased awareness about opioid overdoses, which came
about in large part through Dr. Green’s research, both Connecticut and
Rhode Island passed
Good Samaritan laws
during the course of the study. The laws give people limited immunity
on drug possession charges if they seek medical help for someone
suffering from an overdose. Rhode Island’s new law also promotes and
protects the administration of naloxone by laypersons in a witnessed
overdose.
Another important outcome of the study was educating local officials
that opioid overdoses are not just a problem in major cities, but are
also occurring in towns and suburbs, Dr. Green noted. “Treatment centers
are often located in cities but drug use is everywhere. Limited or no
treatment options – what we call ‘treatment deserts’ – in small towns
and suburbs are contributing to the overdose deaths we are seeing there.
We need to think about how to bring treatment opportunities to troubled
non-urban areas – through satellite centers, using transportation
vouchers to allow clientele to come to the larger treatment centers, or
other options.”
One issue that needs attention in communities, Dr. Green observes –
even in the small towns and suburbs like the ones she studied – is the
high risk of overdose and relapse for prisoners leaving correctional
facilities. “There is a need to work with the incarcerated population
before they leave to get overdose prevention messaging, both for heroin
and prescribed pain medication,” she says. “It needs to be part of
pre-release planning. This is a profound risk that we cannot ignore.”
